CMRX Chimerix Inc

Chimerix Inc is a biopharmaceutical company which focuses on the discovery, development, and commercialization of novel, oral antivirals in areas of unmet medical needs.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/11/2013
Outstanding shares:  87,436,180
Average volume:  4,150,442
Market cap:   $181,867,254
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B8RLM49
Valuation   (See tab for details)
PE ratio:   -1.86
PB ratio:   3.91
PS ratio:   325.34
Return on equity:   -210.44%
Net income %:   -17,994.28%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy